Development of a mass spectrometry-based method for quantification of Ustekinumab in serum specimens
Background:Ustekinumab (UST) is a human monoclonal antibody used to treat moderate-to-severe Crohn disease by blocking the interleukin-12/23 pathway....
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
August 2020
|
| In: |
Therapeutic drug monitoring
Year: 2020, Volume: 42, Issue: 4, Pages: 572-577 |
| ISSN: | 1536-3694 |
| DOI: | 10.1097/FTD.0000000000000734 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/FTD.0000000000000734 Verlag, lizenzpflichtig, Volltext: https://www.ovid.com/jnls/drug-monitoring/fulltext/10.1097/ftd.0000000000000734~development-of-a-mass-spectrometry-based-method-for 
|
| Author Notes: | Nina Scheffe, Rupert Schreiner, Anne Thomann, Peter Findeisen |
| Summary: | Background:Ustekinumab (UST) is a human monoclonal antibody used to treat moderate-to-severe Crohn disease by blocking the interleukin-12/23 pathway.... |
|---|---|
| Item Description: | Gesehen am 11.08.2026 |
| Physical Description: | Online Resource |
| ISSN: | 1536-3694 |
| DOI: | 10.1097/FTD.0000000000000734 |